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Abstract Curcumin is considered not only as a supple-
ment of the diet but also as a drug in many types of
diseases and even as a potential anti-aging compound. It
can reduce inflammation that increases with age and
accompanies almost all age-related diseases. It has been
suggested that curcumin can play a beneficial role in the
cardiovascular system. However, there are also data
showing that curcumin can induce senescence in cancer
cells, which is a beneficial effect in cancer therapy but
an undesirable one in the case of normal cells. It is
believed that cellular senescence accompanies age-
related changes in the cardiovascular system. The aim
of this study was to check if curcumin, in a certain range
of concentrations, can induce senescence in cells build-
ing the vasculature. We have found that human vascular
smooth muscle and endothelial cells derived from aorta
are very sensitive to curcumin treatment and can senesce
upon treatment with cytostatic doses.We observed char-
acteristic senescence markers but the number of DNA
damage foci decreased. Surprisingly, in vascular smooth
muscle cell (VSMC) activation of DNA damage re-
sponse pathway downstream of ataxia-telangiectasia
mutated (ATM) was observed. ATM silencing and the
supplementation of antioxidants, N-acetyl-L-cysteine
(NAC) or trolox, did not reduce the number of senescent
cells. Thus, we have shown that curcumin can induce
senescence of cells building the vasculature, which is
DNA damage and ATM independent and is not induced
by increased reactive oxygen species (ROS) level. We
postulate that an increase in the bioavailability of
curcumin should be introduced very carefully consider-
ing senescence induction as a side effect.
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Introduction
Curcumin has been studied from many years as a po-
tential drug and a protective agent. Abundant evidence
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from molecular studies as well as from animal models
showed efficiency of this factor in treatment of many
diseases due to its anti-inflammatory, antioxidative, and
anti-cancer activities. Recent studies evaluated
curcumin as a potent anti-aging factor and a potent
compound in the prevention of age-related diseases,
including cardiovascular diseases (CVD) (Shen et al.
2013; Sikora et al. 2010). Aging as well as almost all
age-related diseases are accompanied by increased in-
flammation, which in elderly individuals is usually re-
ferred to as persistent low-grade inflammation. It is
believed that by lowering the low-grade inflammation,
curcumin could potentially delay both organismal aging
and age-related diseases, such as neurodegeneration
(AD), cancers, or atherosclerosis. Curcumin acts by
decreasing the proinflammatory cytokine level and oth-
er mediators of inflammation (including NFκB) and by
simultaneously increasing the level and activity of pro-
teins involved in antioxidative defense. There are some
convincing data showing beneficial effects of curcumin
in the vascular system caused by elevation of the level of
heme oxygenase-1 (HO-1), NOS, and sirtuins (Yang
et al. 2013), enzymes considered as essential for protec-
tion of homeostasis in the vascular system.
One of the diseases connected with increased inflam-
mation and classified as an age-related disease is ath-
erosclerosis. The frequency of incidents increases after
the age of 50 years. It has been shown that the produc-
tion of ROS increases as a result of angiotensin II
activity and can lead to damage of cells building the
vasculature (Wang et al. 2010). It is believed that cellu-
lar senescence may be the reason of the organismal
aging. This is especially well documented for cells
building the vasculature. The senescence of vascular
smooth muscle and endothelial cells accompanies both
atherosclerosis and hypertension (Gorenne et al. 2006;
Minamino et al. 2002; Westhoff et al. 2008). Cells
expressing markers of senescence have been found in
atherosclerotic plaques. Such cells possess increased
number of DNA damage foci containing γH2AX, an
increased level of cell cycle inhibitors and higher activ-
ity of senescence-associated β-galactosidase (SA-β-
gal) (Gorenne et al. 2006). It is documented that
curcumin can protect the vascular system and
cardiomyocytes from the damaging activity of chemo-
therapeutic agents, such as doxorubicin (Swamy et al.
2012; Yang et al. 2013). Furthermore, similar to other
plant polyphenols, curcumin can lengthen the life span
of animal model organisms such as Caenorhabditis
elegans, Drosophila melanogaster, and mouse by mod-
ification of the expression of genes involved in cellular
senescence. In the case of C. elegans, curcumin did not
increase the life span of animals with mutated sir2
(mammalian sirtuin 1) (Liao et al. 2011). Long-term
studies have shown that curcumin applied in the diet is
fully safe and can possess protective activity. Even very
high doses of curcumin (8 g/day) did not cause side
effects and in the population in which curcumin consti-
tutes a significant part of the diet, the occurrence of
some diseases is lower (Cheng et al. 2001). Even though
there is no information about the negative effects of
curcumin provided in diet, in vitro curcumin can induce
apoptosis of both normal and cancer cells (Bielak-
Zmijewska et al. 2000). Curcumin belongs to hormetic
agents, i.e., its activity depends on the concentration. At
low concentration, it has a positive effect for the organ-
ism and for particular cells but high concentration may
induce detrimental effects, even cell death. Results ob-
tained by us and by others pointed to a new role of
curcumin, namely the pro-senescence one. It was ob-
served in cancer HCT116, MCF7, and U2OS cells
(Mosieniak et al. 2012) and cancer-associated fibro-
blasts (CAF) (Hendrayani et al. 2013). It was postulated
that in both cases, curcumin could act to protect cells
from cancer progression and the effect can be regarded
as beneficial and of therapeutic significance. However,
it is not difficult to imagine that acceleration of senes-
cence of normal cells could be detrimental. On the other
hand, it has also been postulated that senescence of cells
building vasculature can protect against atherosclerosis
(Muñoz-Espín and Serrano 2014). However, there is
still more evidence that senescence of cells building
the vasculature supports atherosclerosis.
The pro-senescence activity of curcumin observed in
cancer cells inspired us to ask what will happen when
primary cells are exposed to cytostatic doses of this
compound. Therefore, the aim of our study was to
elucidate if curcumin, in concentration which effectively
inhibited proliferation without induction of cell death,
can induce senescence in primary cells building the
vasculature, namely the vascular smooth muscle cells
(VSMCs) and endothelial cells (ECs) derived from the
human aorta. We showed that cells treated with cyto-
static doses of curcumin have undergone senescence in a
DNA damage-independent manner. In spite of the lack
of DNA damage, activation of the DNA damage re-
sponse (DDR) pathway was observed in VSMCs. Our
results also suggest that transient ROS production,
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caused by curcumin, does not evoke cellular senescence
of these cells and that ataxia-telangiectasia mutated
(ATM) does not play a crucial role in curcumin-
induced senescence. The mechanism of curcumin-
induced senescence needs to be elucidated.
Materials and methods
Reagents
Curcumin (C1386) was from Cayman (Ann Arbor,
USA); dimethyl sulfoxide (DMSO) (D4540), bovine
serum albumin (BSA), 4′,6-diamidino-2-phenylindole
(DAPI), and N-acetyl-L-cysteine (NAC) were purchased
from Sigma-Aldrich (Poznan, Poland); DRAQ5 (1,5-
bis{[2-(di-methylamino) ethyl] amino}-4, 8-
dihydroxyanthracene-9,10-dione) was from BioStatus
Limited (Leicestershire, UK); trolox was from
Calbiochem (Warsaw, Poland).
Culture of vascular smooth muscle cells and endothelial
cells
Human VMSCs and ECs were purchased from Lonza or
from ATCC. VSMCs were cultured in SmBM medium
(Lonza, Switzerland) or Vascular Cell Basal Medium
(ATTC, LGC, Poland) supplemented as defined by the
manufacturer. ECs were cultured in EBM-2 medium
(Lonza, Switzerland) or Vascular Cell Basal Medium
(ATTC, LGC, Poland) supplemented as defined by the
manufacturer. All cells were kept in humidified atmo-
sphere (37 °C and 5 % CO2 in the air). The cells were
passaged every 3–4 days and were seeded 24 h before
treatment at a density of 3–3.5×103 cells/cm2 (VSMCs)
and 10×103 cells/cm2 (ECs). To eliminate the overlap-
ping effect of replicative senescence in the experiments,
only cells in the phase of intensive growth have been
used (passage 6–9). Curcumin was dissolved in DMSO
and added to the medium to a given final concentration.
The DMSO concentration in cell culture did not exceed
0.15 %, which did not influence cell survival. Cell mor-
phology was analyzed in the inverted light microscope.
Cell proliferation analysis
Cell proliferation was monitored by assessment of cell
number in the culture. Cells treated with curcumin were
counted in the Neubauer-improved chamber at chosen
time points. For DNA synthesis, bromodeoxyuridine
assay was used (BrdU, Sigma-Aldrich, Poznan, Po-
land). BrdU was added to the medium (10 μM) for
24 h and was detected by using primary antibodies
against BrdU (Becton Dickinson, Warsaw, Poland).
Cells were analyzed under a fluorescence microscope.
Cells were counted, and the % of BrdU-positive cells is
shown on the graphs.
Cell cycle and cell granularity analysis
DNA content and cellular granularity analysis were
made as described by Korwek et.al. (Korwek et al.
2012). Cells were stained with PI solution, and flow
cytometry analysis of 10,000 cells was performed using
FACSCalibur Becton Dickinson and the CellQuestPro
software.
Analysis of mitotic cells—MPM2
Cells were treated with curcumin (2.5–15 μM) or
nocodazole (100 nM) (Sigma-Aldrich, Poznan, Poland)
for the appropriate time, fixed in 4 % PFA and stored in
70 % EtOH at −20 °C. Next, cells were permeabilized
and blocked for 30 min in 3 % BSA and 0.1 % Triton X-
100 (Sigma-Aldrich, Poznan, Poland) in PBS and stained
for 1.5 h with anti-MPM2 antibody (Upstate) diluted
1:1000 in 1 % BSA and 0.1 % Triton X-100 in PBS.
Then, cells were washed and stained for 1 h with second-
ary anti-mouse antibodies conjugated with Alexa Fluor
488 diluted 1:500 in 1 %BSA and 0.1 % Triton X-100 in
PBS. Ten thousand cells were analyzed with the use of
the flow cytometer (FACSCalibur, Becton Dickinson)
and the CellQuestPro software.
Estimation of senescence-associated β-galactosidase
activity
Detection of senescence-associated β-galactosidase
(SA-β-gal) activity was performed according to Dimri
et al. (Dimri et al. 1995). Cells were analyzed in a light
microscope. Then, cells were counted and the % of
SA-β-gal-positive cells is shown.
Measurements of secreted factors
Secretory phenotype was analyzed by ELISA in 1 ml of
the culture medium collected from cell culture on 1, 3,
and 7 days. Experiments were conducted according to
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the protocol provided by the manufacturer (R&D Sys-
tems, Warsaw, Poland). Levels of cytokines (IL-6, IL-8,
VEGF) in the samples were determined with the use of
standard curves and normalized to cell number. Absor-
bance was measured at 450 nm using a Tecan Sunrise
spectrophotometer (Tecan) and analyzed with the X-
fluor 4 software.
RayBio human cytokine antibody array
Selected secreted proteins were also analyzed by
RayBio Human Cytokine Antibody Array (RayBiotech,
Norcross, GA, USA). After 6 days of curcumin treat-
ment, the medium was changed to a fresh one, and 24 h
later, it was collected from cell culture. The protein level
was normalized according to the cell number present in
the dish from which the medium was collected. All
required buffers were provided by the producer. Mem-
branes were blocked for 30 min and incubated with
conditioned media for 2 h. After washing, biotin-
conjugated antibodies were added to each membrane
and incubated for 2 h, and then, HRP-conjugated
streptavidin was added for the next 2 h. Thereafter,
membranes were washed and the signal was developed
using West Pico Chemiluminescent Substrate. Mem-
branes were exposed onto medical X-ray film. Descrip-
tion of the selected proteins is in Table 1.
Western blotting analysis
Whole cell protein extracts were prepared according to
Laemmli (Laemmli 1970). The primary antibodies used
were the following: anti-ATM (1:500), anti-phospho-
ATM Ser1981 (1:500), and anti-GAPDH (1:50,000)
(Millipore, Warsaw, Poland); anti-p53 (1:500), anti-
p21 (1:500), and anti-p16 (1:250) (Santa Cruz Biotech-
nology, Santa Cruz, USA); anti-phospho-p53 Ser15
(1:250) (Becton Dickinson, Warsaw, Poland); anti-HO-
1 (1:1000) (Enzo Life Sciences, Warsaw, Poland);
SIRT1 (1:250), phospho-SIRT1 Ser47 (1:250), anti-
SIRT2 (1:1000), anti-SIRT3 (1:500), anti-SIRT5
(1:500), anti-SIRT6 (1:1000), anti-SIRT7 (1:250), anti-
phospho-p38 Thr180/Tyr182 (1:500), and anti-p38
(1:500) (Cell Signaling Technology, Poznań, Poland);
and anti-AGTR1 (1:500) and anti-actin (1:50,000) (Sig-
ma-Aldrich, Poznan, Poland). The respective proteins
were detected after incubation with one of the horserad-
ish peroxidase-conjugated secondary antibodies
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(Thermo Scientific, Warsaw, Poland), according to the
manufacturer’s instructions.
Global DNA methylation assay
DNA methylation was estimated as the 5-methyl-2′-
deoxycytidine (5-mdC) level using high-performance
liquid chromatography (HPLC) as described elsewhere
(Potocki et al. 2012). For global DNA methylation
inhibition control, a 24-h cell treatment with 5 μM 5-
aza-2′-deoxycytidine (5-aza-dC) was used.
Immunocytochemistry
For detection of 53BP1 foci, cells were fixed with 70 %
ethanol and next incubated with primary anti-53BP1
antibodies (Novus Biological, Cambridge UK) diluted
1:500 and with Alexa 488 secondary antibody (Life
Technology, Eugene, USA), 1:500. DNA was stained
with DAPI. 53BP1 foci were visualized under a fluores-
cence microscope.
Measurement of ROS level
The steady-state level of reactive oxygen species (ROS)
in the cell culture medium and intracellular superoxide
production both total and mitochondrial were measured
with 2′,7′-dichlorodihydrofluorescein diacetate
(H2DCF-DA), dihydroethidium, and MitoSOX™, re-
spectively, as described previously (Mytych et al. 2014).
Mitochondrial membrane potential
The mitochondrial membrane potential (MMP) was
measured with rhodamine G6 as described previously
(Mytych et al. 2014).
Cytokinesis-block micronucleus assay
The evaluation of micronuclei generation was per-
formed using a BD™ Gentest Micronucleus Assay Kit
(Becton Dickinson,Warsaw, Poland) following the stan-
dard protocol provided by the manufacturer as described
previously (Bielak-Zmijewska et al. 2014).
Silencing of the ATM gene
To downregulate ATM expression, the cells were
transfected with 30 nM siRNA (ATM or negative) (Life
Technologies, Warsaw, Poland) using Lipofectamine
2000 (Life Technologies, Warsaw, Poland). Transfec-
tion was performed according to the manufacturer’s
protocol. About 24 h after transfection, medium was
replaced with fresh one and cells were cultured up to
7 days in the presence of curcumin.
Statistical analysis
Statistical analysis was performed using two-tailed Stu-
dent t test or ANOVA with post hoc testing using a
Dunnett’s multiple comparison test. Data are presented
as a mean±SD. A value of p<0.05 was considered sta-
tistically significant (*p<0.05, **p<0.01, ***p<0.001).
All graphs show the mean results from at least three
independent experiments.
Results
VSMC and EC sensitivity to curcumin treatment
VSMCs and ECs derived from the human aorta have
been studied for their sensitivity to curcumin (Fig. 1a).
Already at 10 μM concentration of curcumin, VSMCs
started to die. Cells stopped to proliferate in the presence
of 5 μM curcumin. Analysis of BrdU incorporation
revealed that the number of cells that were able to syn-
thesize DNAwithin 18 h decreased at 2.5 μM curcumin,
and at 7.5 μM, the inhibition seemed to be more effective
(Fig. 1b). For ECs, the 2.5 μM concentration inhibited
cell proliferation (the incorporation of BrdU was almost
totally inhibited) (Fig. 1a, b) while 10 μM and higher
concentrations were cytotoxic. Our results revealed that
concentrations below 1 μM did not influence VSMC
proliferation but slightly inhibited that of ECs, as shown
by cell counting and BrdU incorporation (Fig. 1b). In
spite of the cell death observed after curcumin treatment,
the sub-G1 fraction of cells corresponding to the popula-
tion of apoptotic cells with fragmented DNA (level lower
than 2C) was insignificant for both VSMCs (about 2 %)
and ECs (about 8 %) (not shown).
For VSMCs and ECs, the cell cycle analysis was
performed (Online Resource 1). In VSMCs, the range
of curcumin concentrations (between 5 and 15 μM)
induced changes in the cell cycle, manifested by in-
creased population of cells in the G2/M phase. In ECs,
no changes in the proportion of cells in the particular
phases of the cell cycle were observed.
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In order to check whether cells containing 4C DNA
accumulated in the G2 or M phase of the cell cycle, we
analyzed the percentage of MPM2-positive cells (On-
line Resource 2). Cells treated with nocodazole, the
inhibitor of microtubule polymerization which arrests
cells during mitosis, served as a positive control. For
untreated cells, the percentage of mitotic cells was about
2–3 %. We showed that curcumin did not increase the
number of cells in mitosis. The observed low percentage
of MPM2-positive cells suggests that curcumin arrested
cells in the G2 phase of the cell cycle.
Curcumin induces cellular senescence of human
VSMCs and ECs in vitro
To study the long-term effect of cytostatic concentra-
tions of curcumin, VSMCs and ECs were cultured in the
presence of curcumin for a few days. For VSMCs 5–
7.5 μM and for ECs 2.5–5 μM, concentrations have
been chosen. Cells treated with these concentrations of
curcumin demonstrated some markers characteristic for
senescence. In both types of cells, increased SA-β-gal
activity was observed (Fig. 2a). After 7 days, about
80 % of VSMCs (Fig. 2a) and about 70 % of ECs
Fig. 1 Proliferation potential of VSMCs and ECs treated with
different concentrations of curcumin. a Proliferation potential
measured by counting VSMCs and ECs (curcumin between
10 nM and 15 μM). The concentration of DMSO in control
(0.15 %) corresponded to the concentration of DMSO added to
the culture medium with the highest curcumin dose. b Estimation
of proliferation rate by measurement of DNA synthesis as BrdU
incorporation in VSMCs and ECs (curcumin between 10 nM and
10 μM). The percentage of BrdU-positive cells is presented on the
graphs. 1-3d 1–3 days after curcumin treatment. Error bars indi-
cate SD, n=3 or more. t test, *p<0.05, **p<0.01, ***p<0.001,
compared to control cells.
Fig. 2 Analysis of the selected markers of senescence upon
treatment with cytostatic doses of curcumin (5 μM for VSMCs
and 2.5μM for ECs). a SA-β-gal activity in VSMCs and ECs. The
graphs with the percentage of SA-β-gal-positive cells and repre-
sentative pictures are shown. Magnification ×200. b Secretory
phenotype (SASP) of VSMCs and ECs. The level of IL-6, IL-8,
and VEGF was shown. 1-7d 1–7 days after curcumin treatment.
Error bars indicate SD, n=3 or more. t test, *p<0.05, **p<0.01,
***p<0.001, compared to control cells. c Changes in selected
secreted protein level in VSMCs measured using RayBio Human
Cytokine Antibody Array. The respective membranes represent
control cells, cells treated with 5 μM curcumin, and pure medium
to exclude unspecific changes in protein level: 1 IL-4, 2 IL-6, 3 IL-
GR, 4 IL-8, 5 GROα, 6 OPG, 7 EGF, 8 bFGF, 9 TIMP1, and 10
TIMP2. The level of the secreted proteins was estimated in culture
medium collected after 24 h after culturing from control and
curcumin-treated cells (6 days with curcumin and 24 h in a fresh
medium). Additional control was performed with medium that
was not used for cell culture. The level of proteins which increased
is marked with rectangles and those which level decreased with
rounded rectangles.
b
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(Fig. 2a) were SA-β-gal positive. The secretory pheno-
type was manifested by increased production of IL-6
and IL-8 in both types of cells (Fig. 2b). In the case of
VEGF, increased secretion was observed only in
VSMCs, while the level of this growth factor decreased
in ECs. In VSMCs, the level of selected secreted pro-
teins after curcumin treatment was studied using the
RayBio Human Cytokine Antibody Array (Fig. 2c and
Table 1). We found that the level of eight proteins
increased in curcumin-senescent cells and the level of
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two proteins decreased. Elevated proteins were IL-4 (1),
IL-6 (2), IL-GR (3), IL-8 (4), growth-related oncogene
α (GROα) (5), osteoprotegerin (OPG) (6), tissue inhib-
itors of metalloproteinases 1 (TIMP1) (9), TIMP2 (10),
and those alleviated were EGF (7) and bFGF (8). The
inhibition of proliferation was irreversible. After
removal of curcumin, cells were cultured for 3–4 weeks
without resuming proliferation. Therefore, we conclud-
ed that curcumin induced senescence.
During curcumin-induced senescence of VSMCs,
enhanced cellular granularity was observed (Fig. 3a). It
was detected in about 12 % of cells after 7-day
Fig. 3 Analysis of selected senescence markers upon cytostatic
curcumin doses. a Granularity of VSMCs upon 7.5 μM curcumin
expressed as the percentage of cells with increased granularity. b
Cell cycle analysis of VSMCs treated with 7.5 μM curcumin. The
graphs show% of cells in the particular phases of the cell cycle. 1-
7d 1–7 days after curcumin treatment. Error bars indicate SD, n=
3 or more. t test, *p<0.05, **p<0.01, ***p<0.001, compared to
control cells. c Morphology of VSMCs treated with 5 μM
curcumin. Representative pictures are shown. d Western blot
analysis of AT1R and HO-1 during curcumin-induced senescence
of VSMCs (5 μM curcumin). Actin served as a loading control. e
Western blot analysis of HO-1 during curcumin-induced senes-
cence of ECs (2.5 μM curcumin). Actin served as a loading
control. f Western blot analysis of sirtuin 1 and 6 levels and
phosphorylation of sirtuin 1 in VSMCs (5 μM curcumin) and
ECs (2.5 μM curcumin).
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treatment. No spectacular changes were observed in
ECs. Cell accumulation in the G2 phase of the cell cycle
accompanied VSMC senescence (Fig. 3b).We observed
also an increased cell size and changed morphology of
the cells (Fig. 3c). In VSMCs, the level of AT1R, the
receptor of angiotensin II, increased after curcumin
treatment (Fig. 3d). Opposite situation was observed
for HO-1, an enzyme responsible for antioxidative de-
fense, especially important for EC homeostasis. The
level of this enzyme decreased in both types of cells
upon curcumin treatment (Fig 3d, e).We did not observe
any changes in global DNA methylation (Online Re-
source 3) in VSMCs as a result of curcumin-induced
senescence. We also analyzed the level of two sirtuins
involved, among others, in DNA repair, longevity, and
proper functioning of the vascular system, namely
sirtuin 1 (total and phosphorylated form) and sirtuin 6
(Fig. 3f). In VSMCs, the level of both sirtuins decreased
and was undetectable after 7 days. In ECs, a transient
increase was observed, but after 7 days, the level of
sirtuin 1 decreased visibly while that of sirtuin 6 only
slightly and was still higher than the starting point level
in untreated cells.
Mechanism of cell senescence induced by curcumin
treatment
Role of DNA damage in curcumin-induced senescence
DNA damage is one of the most common causes of the
stress-induced premature senescence. We analyzed the
number of DNA damage foci by immunocytochemical
detection of the 53BP1 protein (Fig. 4a). We distin-
guished four categories of cells with damaged DNA,
depending on the number of foci (one focus represents
one double-strand break). The first category included
cells without DNA double-strand break (DSB); the sec-
ond, cells with only one focus; the third, cells with the
number of foci between 2 and 5; and the fourth, cells
withmore than five foci. After curcumin treatment in the
case of both VSMCs and ECs, the number of cells with
more than five foci was lower than in control cells.
Besides, in the case of VSMCs, the number of cells
without DNA DSB increased. Moreover, we showed
that, unlike genotoxic agents, curcumin did not induce
micronucleation (Fig. 4b). However, curcumin induced
the DNA damage response pathway in VSMCs
(Fig. 4c). For example, the elevated level of ATM was
observed and it correlatedwith an increase in the level of
the phosphorylated form of this protein. Also, the level
of total and phosphorylated p53 increased, as well as the
level of its target protein, p21, an inhibitor of the cyclin-
dependent kinases. No changes were observed in the
level of another cell cycle inhibitor, namely p16, but the
elevation of the level and phosphorylation of p38, a
kinase belonging to MAPK and involved in the senes-
cence growth arrest, accompanied the curcumin-
induced senescence. In the case of ECs (Fig. 4c), ATM
level was relatively high in control cells and decreased
upon curcumin treatment, but the level of the phosphor-
ylated formwas constant. The level of p53 increased but
its phosphorylated form was observed only after 1-day
treatment then gradually decreased. This was consistent
with the transient elevation of p21. The p16 level in-
creased gradually, and the level of phosphorylation of
p38 increased after 24 h but the level of p38 did not
change.
As it has been shown above, curcumin induces DNA
damage-independent activation of the DDR pathway in
VSMCs. However, in ECs, DDR pathway activation is
not observed, but in both types of cells, senescence is
DNA damage independent.
Role of ROS in curcumin-induced senescence of VSMCs
Because we showed that DNA damage was not the
cause of the senescence, we asked what could induce
the DDR pathway in VSMCs and, in consequence, be
responsible for senescence induction. There are data
suggesting that ATM can be activated directly by oxi-
dative stress (Guo et al. 2010).
The first step to study the mechanism of senescence
induction by curcumin in VSMCs was to measure the
level of ROS production. We observed an increased
steady-state level of total ROS in the culture medium
of curcumin-treated cells (Fig. 5a). Intracellular super-
oxide production in untreated cells increased during the
culture, but in curcumin-treated cells, the production
was elevated only after 1 and 3 days in comparison to
the control cells (Fig. 5b). Seven days after treatment, it
was lower than in the control one. An increase in the
intracellular mitochondrial superoxide production was
observed during the whole time of treatment in compar-
ison to control cells, where the production was constant
during the culture period (Fig. 5c). Curcumin mediated
also a change in the mitochondrial membrane potential
(Fig. 5d). The mitochondrial membrane potential grad-
ually decreased in untreated cells. In curcumin-treated
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cells, the mitochondrial membrane potential on the first
and the third days was lower than in the control cells but
on the seventh day was higher than in the control. We
analyzed the level of sirtuins present in mitochondria,
which are involved in energy homeostasis, mitochon-
drial biogenesis, and reduction of ROS and participate in
cardiac homeostasis as well as aging (Park et al. 2013).
In both types of cells, the elevation of the level of sirtuin
3 and 5 was observed (Fig. 5e).
As we found out, in VSMCs, curcumin increased the
intracellular ROS production even on the third day of
treatment. Increased ROS production resulted probably
from the increased mitochondrial superoxide produc-
tion. It was inversely correlated with mitochondrial
membrane potential. To establish the role of ROS in
curcumin-induced senescence of VSMCs, we supple-
mented the culture medium of cells treated with
curcumin with classic antioxidants, namely trolox and
NAC (N-Acetyl-L-cysteine) (30-min pretreatment).
Such concentrations of antioxidants were chosen exper-
imentally so as not to impair cell proliferation. Our
results revealed that neither trolox nor NAC improved
proliferation of cells treated with curcumin nor reduced
the number of senescent cells (Fig. 6a, b). We did not
observe any differences between cells which were treat-
ed with NAC together with curcumin and cells which
were only treated with curcumin. Trolox together with
curcumin caused an elevated rate of cell death. We
analyzed the DDR pathway as well as the proteins
markers of senescence established earlier for this type
of cells, namely AT1R and HO-1. We could not observe
any differences in the protein levels between cells which
were only treated with curcumin and those which were
pretreated with NAC or trolox (not show).
Our results showed that curcumin-induced senes-
cence of VSMCs was accompanied by oxidative stress,
but the antioxidant intervention failed to overcome the
pro-senescent activity of curcumin.
Role of ATM in curcumin-induced senescence
We also checked if ATM was in general responsible for
curcumin-induced senescence of VSMCs. To this end,
we silenced the ATM protein with specific siRNA and
we analyzed the number of senescent cells upon
curcumin treatment. The silencing of ATMwas effective
but did not reduce the number of senescent cells, as it
has been shown by SA-β-gal analysis after 7-day treat-
ment (Fig. 6c, d). Cells transfected with siRNA (ATMor
scramble) and not treated with curcumin proliferated in
a similar manner as control cells, and the number of
SA-β-gal-positive cells was almost the same. It sug-
gested that curcumin-induced cell senescence is ATM
independent.
Discussion
The results of this study revealed that curcumin’s effect
on VSMCs and ECs is concentration and cell type
dependent. The cytostatic concentrations for ECs were
between 2.5 and 5 μM, and for VSMCs between 5 and
7.5 μM. Higher concentrations were cytotoxic. Interest-
ingly, 10 μM concentration was not cytotoxic for fibro-
blasts and human HaCaT keratinocytes (Hendrayani
et al. 2013; Zhao et al. 2013).
We analyzed the impact of cytostatic concentrations
till the seventh day of culture. Such concentrations of
curcumin induced cellular senescence in both types of
cells. Curcumin-induced senescence was evidenced by
altered cell morphology, increased granularity, and ac-
cumulation of VSMCs in the G2 phase of the cell cycle.
This has been already described as one of the markers of
stress-induced premature senescence (SIPS) in VSMCs
(Bielak-Zmijewska et al. 2014). MPM2 analysis re-
vealed only few mitotic cells after curcumin treatment
and suggested that cells were accumulated in the G2
phase of the cell cycle, not in mitosis. It has been
observed in cells undergoing prolonged mitosis that
the proteins protecting telomeres were dispersed which
provoked senescence induction (Hayashi et al. 2012).
We have shown earlier that curcumin caused a mitotic
spindle dysfunction by its impact on microtubules
(Bielak-Zmijewska et al. 2010), and this could be the
reason of a prolonged mitotic arrest and telomere
Fig. 4 The role of DNA damage in curcumin-induced senescence
of VSMCs and ECs. a DNA damage expressed as the number of
DNA DSBs visualized by 53BP1 immunocytochemistry in
VSMCs and ECs (curcumin 5 and 2.5 μM, respectively). 0 cells
without DNA damage, 1 with only one focus, 2-5 with number of
foci between 2 and 5, >5 cells with more than five foci. 1-7d 1–
7 days after curcumin treatment. Error bars indicate SD, n=3 or
more. t test, *p<0.05, **p<0.01, ***p<0.001, compared to con-
trol cells. b Micronuclei generation in VSMCs upon curcumin
treatment. Graph and representative pictures are shown. Arrow-
head indicates a cell with a micronucleus. cWestern blot analysis
of proteins belonging to DDR pathway and proteins involved in
cellular senescence.
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proteins diffusion. However, on the basis of the current
results, we can exclude that curcumin induced senes-
cence in VSMCs and ECs by mitosis prolongation.
As a result of curcumin-induced senescence, an in-
creased level of angiotensin II receptor, AT1R, was
observed (only in VSMCs). AT1R is a cell-type specific
marker of VSMC senescence (Stegbauer and Coffman
2011). In both ECs and VSMCs, the level of HO-1
decreased, which pointed to the impaired antioxidative
defense. It has been observed earlier in carotid bodies in
rats that the level of HO-1 decreased with age (Di Giulio
et al. 2009). Moreover, increased HO-1 level protected
cells from senescence (Clérigues et al. 2012). It was
documented that curcumin induced HO-1 in a short-
term cell treatment (Lima et al. 2011), and this effect is
considered beneficial in both cardiovascular protection
and anti-aging intervention.
We observed increased activity of SA-β-gal and
senescence-associated secretory phenotype (SASP)
manifested by an increased level of IL-6 and IL-8. It
Fig. 5 Oxidative stress parameters of VSMCs treated with
curcumin. a Total ROS level in the culture medium (5 μM
curcumin). Data are presented as relative fluorescence unit
(RFU). b Intracellular total superoxide production (5 μM
curcumin). RFU per minute. c Intracellular mitochondrial super-
oxide production (5μMcurcumin). RFU per minute. dChanges in
mitochondrial membrane potential (MMP) (5 μM curcumin). Data
are presented as RFU. 1-7d 1–7 days after curcumin treatment.
Error bars indicate SD, n=3 or more. ANOVA with post hoc
testing using a Dunnett’s test, *p<0.05, **p<0.01, ***p<0.001,
compared to control cells. eWestern blot analysis of mitochondrial
sirtuin 3 and 5 (7.5 μM curcumin for VSMCs and 2.5 μM for
ECs).
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has been shown earlier that curcumin reduces inflamma-
tion by decreasing IL-6 (Cho et al. 2007) and IL-8 levels
(Cohen et al. 2009). Moreover, in cancer-associated fi-
broblasts (CAF) undergoing senescence as a result of
curcumin treatment, SASP has not been observed
(Hendrayani et al. 2013). In VSMCs, also, the production
of VEGF increased, but in ECs, an opposite tendency
was observed. We speculate that the reduction of VEGF
in ECs is a cell-type-specific marker of senescence, and
the elevation in VSMCs is the result of SASP (increased
VEGF is a feature of SASP). It has been described that
decreased level of VEGF is a characteristic feature of EC
senescence (Ahluwalia et al. 2014). There are also data
showing that curcumin was able to reduce the level of
this growth factor and in this manner protected against
angiogenesis-accompanied metastasis (Gururaj et al.
2002; Shao et al. 2002). We also analyzed the changes
in the level of selected secreted proteins during
curcumin-induced senescence in VSMCs. The level of
some of them increased, for example those associated
with inflammation: IL-4 and GROα or inhibitors of
metalloproteinases, TIMP1 and TIMP2.
Interesting is the result showing the increased secre-
tion of osteoprotegerin (OPG) by curcumin. It has been
evidenced that this protein protects cells from calcifica-
tion, which is one of the characteristic features of VSMC
senescence (Bennett et al. 2006). Calcification is strongly
correlated with atherosclerosis, and the protective effect
Fig. 6 The role of ROS and ATM in curcumin-induced senes-
cence of VSMCs. a The proliferation rate of VSMCs pretreated for
30 min with antioxidants NAC (1 μM) and trolox (tx) (500 nM)
and next treated with 7.5 μM curcumin (cell counting). The
number of untreated cells is taken as 100 %. The concentrations
of antioxidants were chosen experimentally and doses which did
not affect proliferation were used. b The percentage of SA-β-gal-
positive cells after 30 min pretreatment with NAC (1 μM) and
subsequent treatment with 7.5 μM curcumin. c Influence of ATM
silencing on the ability of VSMCs to undergo senescence. The
number of SA-β-gal-positive cells as a result of curcumin treat-
ment and in cells which were transfected with siRNA (negative or
ATM) without treatment with curcumin is presented on the graph.
1-7d 1–7 days after curcumin treatment. Error bars indicate SD,
n=3 or more. d The efficiency of ATM silencing (after 48 h) is
shown on the Western blot.
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of curcumin against vascular cells mineralization could
be considered as a new beneficial activity of this com-
pound. Our preliminary results suggest that the expres-
sion of OPGwasmaintained and was even higher in cells
undergoing curcumin-induced senescence.
Since cells senesced after curcumin treatment, we
investigated whether free radicals play a role in this
process. It is well documented that curcumin possesses
antioxidative activity but there are also data suggesting
that it can induce a prooxidative response (Sandur et al.
2007). Our data have shown that curcumin increased
ROS level in the medium, mitochondrial superoxide
production, and intracellular ROS level but only during
the first days of treatment. Subsequently, the level of
cellular ROS was significantly lower than in control
cells. However, mitochondrial superoxide production
was still higher compared to untreated cells, which
together with decreased HO-1 expression may indicate
that curcumin induced oxidative stress and impaired the
antioxidative defense during cellular senescence. Oppo-
site correlation was observed for the mitochondrial
membrane potential, which decreased during the first
3 days and increased at day 7 whichmight be interpreted
as adaptation to a long-term exposure to cellular
(oxidative) stress. The increased mitochondrial mem-
brane potential in senescence was observed earlier
(Sugrue et al. 1999). Interestingly, curcumin increased
the level of mitochondrial sirtuins 3 and 5. These pro-
teins are activated in response to stress conditions, and
sirtuin 3 appears to be an antioxidant protein, because it
can reduce ROS by deacetylation which leads to the
activation of superoxide dismutase 2 (SOD2) (Chen
et al. 2011). Sirtuin 3 is involved in aging and cardiac
homeostasis, and its overexpression is protective against
cardiac hypertrophy while depletion enhances the sus-
ceptibility to hypertrophy (Sundaresan et al. 2009). We
cannot exclude that the elevation of mitochondrial
sirtuins is characteristic for dual curcumin action. It
could represent the protective mechanism induced by
an increased ROS production as a result of curcumin
treatment (curcumin simultaneously leads to ROS gen-
eration and activates some proteins which participate in
an antioxidative defense). It has been shown by others
that the level of sirtuin 3 decreased with age (Brown
et al. 2013). Moreover, it has been shown that ectopi-
cally expressed sirtuin 3 partially reverses the age-
associated functional decline of murine hematopoietic
stem cells (Brown et al. 2013). The role of mitochon-
drial sirtuins in senescence needs to be elucidated.
To establish the mechanism of senescence induction
upon curcumin treatment, we analyzed the ability of
curcumin to induce DNA damage. DNA damage is
one of the most common causes of cellular senescence
(Sedelnikova et al. 2004) what was also shown by us in
VSMCs treated with doxorubicin (Bielak-Zmijewska
et al. 2014). There are contradictory data concerning
curcumin; in some papers, evidence can be found that
curcumin induces DNA damage (Blasiak et al. 1999;
Cao et al. 2006) but our earlier results (Bielak-
Zmijewska et al. 2000) as well the result obtained by
others (Hendrayani et al. 2013) show that it does not.
Surprisingly, we found out that cells senescing upon
curcumin treatment possessed less DNA damage foci
than untreated cells. However, the DNA damage re-
sponse (DDR) pathway, namely ATM, and p53 were
activated in VSMCs. Cellular senescence with pseudo-
DNA damage response has already been described, and
the authors suggested that activation of the DDR path-
way was rather a consequence of senescence and not the
cause. (Pospelova et al. 2009).
We studied also the level of other proteins involved in
cellular senescence, such as the cell cycle inhibitor p16.
The level of p16 increased in ECs but was unchanged in
VSMCs. The p38 protein is activated normally as a result
of acute cellular stress and leads to cell growth arrest due
to its ability to activate both p53 and pRb/p16 (Freund
et al. 2011). It has been shown that p38 activity is neces-
sary and sufficient for development of SASP in DNA
damage-induced senescence, independently of the DDR
pathway. In our experiments, despite the lack of DNA
DSBs, the level of phosphorylated p38 increased in both
types of cells. It has been shown that curcumin was able
to inhibit p38 protein expression (Shehzad et al. 2010).
There are data showing that the DDR pathway acti-
vation can be the result of direct activation of ATM by
ROS (Guo et al. 2010), and we established that
curcumin induced ROS production. However, our re-
sults showed that neither trolox nor NAC reduced the
percentage of senescent cells and influenced the level of
proteins from the DDR pathway. Moreover, cells treated
with curcumin together with trolox showed increased
mortality. Such effect was earlier shown for cancer cells
where trolox enhanced the cytotoxicity of curcumin
(Zheng et al. 2012). We also silenced ATM, and it did
not prevent VSMC senescence. This suggests that
curcumin-induced senescence is ATM independent.
ATM-independent senescence was observed by us also
in ECs in which no increased level or phosphorylation
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of ATM was detected. ATM-independent senescence
has been shown in primary fibroblasts derived from
patients with ataxia-telangiectasia and was induced by
p38 activation. (Barascu et al. 2012).
We analyzed the impact of curcumin on sirtuins level.
Sirtuins are NAD-dependent deacetylases. These en-
zymes regulate transcription of genes and are involved
in many cellular processes including inflammation, DNA
repair, telomere structure and genome integrity mainte-
nance and are considered as anti-aging agents (Morris
2013). It is documented that the level of sirtuin 1 and 6 as
well as the efficiency of both DNA repair systems, ho-
mologous recombination (HR) and non-homologous end
joining (NHEJ) decreased during aging (Mao et al. 2012;
Seluanov et al. 2004). On the other hand, it is believed
that curcumin increases the level of some sirtuins and in
this manner exerts its beneficial effect for the organism.
In cells senescing upon curcumin treatment, the level of
sirtuin 1 and 6 decreased.
This discrepancy could be due to the overlapping of
two effects, i.e., one characteristic for curcumin activity
(early response) and second, resulting from senescence
(late response). Such conclusion seems justified since
most often, the initial response was typical for the
known beneficial activity of curcumin (increased level
of sirtuins 1 and 6 or HO-1 at day 1) and only later on
became characteristic for senescence.
It is the first report concerning the ability of curcumin
to induce senescence of cells building the vasculature. To
our knowledge, there is only one published paper show-
ing that curcumin can induce senescence of primary cells
(Hendrayani et al. 2013). Authors of this paper showed
that curcumin could induce senescence of cancer-
associated fibroblasts (CAF) in a DNA-independent
manner, which is consistent with our results. Senescence
of these types of cells is recognized as a beneficial effect
due to decreased migration/invasion ability. The authors
of the paper argued that curcumin-induced senescence
could be termed Bsafe,^ because it did not cause DNA
DSB, SASP, and protected from metastasis. However, in
VSMCs and ECs, at least some protein characteristics for
SASP were detected. Previously, we have shown that
curcumin can induce senescence of cancer cells, e.g.,
HCT116. This phenomenon can be considered as impor-
tant for anti-cancer therapy but the induction of senes-
cence of normal cells would have a negative impact on
the organism. However, it has also been postulated that
senescence of VSMCs could protect against atheroscle-
rosis (Muñoz-Espín and Serrano 2014). But until now,
more evidence supports the contribution of senescence to
atherosclerosis progression. It cannot be excluded that
the role of senescence depends on the advancement of
atherosclerosis and can change with age similar to the
role of cellular senescence in general (positive impact in
young individuals and detrimental in elderly) (López-
Otín et al. 2013). The bioavailability of curcumin is very
low, and the activity is short-lived because of its fast
metabolism. It was taken for granted that doses not
harmful for the organism should not cause time-
delayed detrimental effects on the cellular level. Howev-
er, our results reveal that curcumin concentrations induc-
ing senescence of vascular cells are very close to doses
detected in blood after curcumin consumption. We ob-
served cellular senescence after using curcumin in 2.5–
5 μM concentrations range, and the highest concentra-
tion described in the serum was 3.6 μM (Cheng et al.
2001). Such a concentration was observed after con-
sumption of an extremely high, therapeutic dose, which
was administered during cancer therapy. During normal
consumption, much lower concentrations of curcumin
(nanomolar) are obtained (Anand et al. 2007). Despite
the fact that curcumin seems to be a promising agent in
slowing-down aging, one should keep in mind that its
improved bioavailability and its long-term administra-
tion might have an opposite effect and it could accelerate
aging, for example by inducing senescence of primary
cells building the vasculature.
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